Clinical Trial Update: Immunogenicity and Safety of Two Different Commercial EV71 Vaccines [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating immunogenicity and safety of two commercial EV71 vaccines for Hand, Foot and Mouth Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 vaccine (commercial multiple/hard to specify)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: COMPLETED